4//SEC Filing
Roberts Christopher D. 4
Accession 0000899243-21-007445
CIK 0001701541other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:01 PM ET
Size
5.6 KB
Accession
0000899243-21-007445
Insider Transaction Report
Form 4
Roberts Christopher D.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-17+75,000→ 75,000 totalExercise: $28.69Exp: 2031-02-16→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 17, 2022, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001788368
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:01 PM ET
- Size
- 5.6 KB